Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Raimondo

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cryobiology|January 29, 2011
Consequences of metaphase II oocyte cryopreservation on mRNA contentS Chamayou, G Bonaventura, C Alecci, et al.
Haematologica|November 1, 1995
Cutaneous vasculitis in non Hodgkin's lymphomaG Milone, F Stagno, P Guglielmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabineF Di Raimondo, R Giustolisi, S Lerner, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Leukemia & Lymphoma|June 1, 1997
Evaluation of Taxol cytotoxicity on B-CLL cells in vitroF Di Raimondo, G A Palumbo, M A Romeo, et al.
Haematologica|August 16, 2000
Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral bloodF Di Raimondo, M P Azzaro, G Palumbo, et al.
British Journal of Haematology|July 27, 2001
Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319M Prella, R Baccalà, J D Horisberger, et al.
Case Reports in Hematology|December 16, 2014
Oral lesion as unusual first manifestation of multiple myeloma: case reports and review of the literatureA Romano, M S Marescalco, Chiara Liardo, et al.
Leukemia & Lymphoma|May 1, 1995
In vitro sensitivity of B-CLL cells to fludarabine and interferonsF Di Raimondo, G A Palumbo, M A Romeo, et al.
European Journal of Haematology|January 1, 1996
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical studyF Di Raimondo, G Longo, E Cacciola, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cryobiology|January 29, 2011
Consequences of metaphase II oocyte cryopreservation on mRNA contentS Chamayou, G Bonaventura, C Alecci, et al.
Haematologica|November 1, 1995
Cutaneous vasculitis in non Hodgkin's lymphomaG Milone, F Stagno, P Guglielmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabineF Di Raimondo, R Giustolisi, S Lerner, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Leukemia & Lymphoma|June 1, 1997
Evaluation of Taxol cytotoxicity on B-CLL cells in vitroF Di Raimondo, G A Palumbo, M A Romeo, et al.
Haematologica|August 16, 2000
Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral bloodF Di Raimondo, M P Azzaro, G Palumbo, et al.
British Journal of Haematology|July 27, 2001
Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319M Prella, R Baccalà, J D Horisberger, et al.
Case Reports in Hematology|December 16, 2014
Oral lesion as unusual first manifestation of multiple myeloma: case reports and review of the literatureA Romano, M S Marescalco, Chiara Liardo, et al.
Leukemia & Lymphoma|May 1, 1995
In vitro sensitivity of B-CLL cells to fludarabine and interferonsF Di Raimondo, G A Palumbo, M A Romeo, et al.
European Journal of Haematology|January 1, 1996
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical studyF Di Raimondo, G Longo, E Cacciola, et al.
Pageof 6